Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of GeneDx Holdings (NasdaqGS:WGS) with a ...

Fintel reports that on December 12, 2025, BTIG maintained coverage of GeneDx Holdings (NasdaqGS:WGS) with a Buy recommendation. Analyst Price Forecast Suggests 5.62% Upside As of December 6, 2025, the ...

The projected fair value for GeneDx Holdings is US$253 based on 2 Stage Free Cash Flow to Equity GeneDx Holdings' US$152 share price signals that it might be 40% undervalued The US$165 analyst price ...

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.

GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced that the GUARDIAN (Genomic Uniform-screening Against Rare Disease In All Newborns) study has been ...

Detailed price information for Xtant Medical Holdings Inc (XTNT-A) from The Globe and Mail including charting and trades.

The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

Travelport, a leading multi-source content provider powering travel bookings for suppliers worldwide, today announced that Greg Webb has notified the Board of Directors that he has decided to step ...

The main market opportunities lie in expanding Whole Genome Sequencing at birth, rapid growth in Direct to Consumer Testing, advancing sequencing technologies, and overcoming industry barriers.